One-year prospective study of a HEMA-based hydrophobic acrylic trifocal IOL (Clareon PanOptix): visual performance, patient-reported outcomes, and optic clarity

一项为期一年的前瞻性研究,评估基于HEMA的疏水性丙烯酸酯三焦点人工晶状体(Clareon PanOptix):视觉表现、患者报告结果和光学清晰度

阅读:1

Abstract

While Clareon monofocal intraocular lens (IOL) has been reported to be free from surface light scattering and glistenings, it remains unknown whether Clareon PanOptix IOL develops these optical phenomena. This study aimed to evaluate one-year surgical outcomes of this IOL, with a focus on visual function, patient-reported satisfaction, and clarity of IOL optics. A prospective study was conducted in 78 eyes of 39 patients undergoing bilateral implantation of toric or non-toric Clareon PanOptix IOLs. Postoperative examinations were conducted at 1, 6, and 12 months. At 12 months, bilateral uncorrected visual acuity (BUCVA) and bilateral distance-corrected visual acuity (BDCVA) were better than 20/20 at 40 cm, 60 cm, and 5 m. No cases of surface light scattering or glistenings were observed. Spectacle independence was achieved in 84.2% of patients. While patient satisfaction with vision in daily life and daytime driving was high, approximately half of the patients reported some difficulty with night driving. The Clareon PanOptix provided satisfactory surgical outcomes, with no formation of surface light scattering or glistenings during the one-year follow-up period.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。